Biophytis Provides Updates on Sarconeos (BIO101) Clinical Development

Sarcopenia (SARA) : discussions engaged with FDA for the preparation of a Phase 2-3 program in sarcopenia, with the objective of having a First Patient In by end of H2 2022COVID-19 (COVA): 237 patients enrolled - early termination of recruitment due …